Cargando…
Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug
BACKGROUND: Human African trypanosomiasis (HAT or sleeping sickness) is caused by the parasite Trypanosoma brucei sspp. The disease has two stages, a haemolymphatic stage after the bite of an infected tsetse fly, followed by a central nervous system stage where the parasite penetrates the brain, cau...
Autores principales: | Sanderson, Lisa, da Silva, Marcelo, Sekhar, Gayathri N., Brown, Rachel C., Burrell-Saward, Hollie, Fidanboylu, Mehmet, Liu, Bo, Dailey, Lea Ann, Dreiss, Cécile A., Lorenz, Chris, Christie, Mark, Persaud, Shanta J., Yardley, Vanessa, Croft, Simon L., Valero, Margarita, Thomas, Sarah A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078842/ https://www.ncbi.nlm.nih.gov/pubmed/33857146 http://dx.doi.org/10.1371/journal.pntd.0009276 |
Ejemplares similares
-
Safer drugs for children.
Publicado: (1999) -
Portugal’s voluntary food reformulation agreement and the WHO reformulation targets
por: Goiana-da-Silva, Francisco, et al.
Publicado: (2019) -
Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications
por: Murteira, Susana, et al.
Publicado: (2014) -
Decoding the network of Trypanosoma brucei proteins that determines sensitivity to apolipoprotein-L1
por: Currier, Rachel B., et al.
Publicado: (2018) -
Use of Allosteric Targets in the Discovery of Safer Drugs
por: Grover, Ashok Kumar
Publicado: (2013)